A Phase 1 Study of [225Ac]-FPI-1434 Injection
Fusion Pharmaceuticals Inc.
Fusion Pharmaceuticals Inc.
Tempus AI
Incyte Corporation
Bolt Biotherapeutics, Inc.
NuCana plc
Aminex Therapeutics, Inc.
Fate Therapeutics
University of Iowa
CureOne
Otsuka Novel Products GmbH
Calando Pharmaceuticals